Practice Management
The Food and Drug Administration unveiled a new tool designed to give urgent care physicians and other providers more timely access to updates on antibiotics and antifungal drugs this week. The overarching aim is to help clinicians anticipate when bacterial or fungal infections are likely to respond to a specific drug. Under the new approach, FDA can simultaneously update the breakpoints for multiple drugs that have the same active ingredient and share that information transparently …
Read More
The Centers for Disease Control and Prevention has issued a Health Advisory to warn clinicians of emerging Shigella strains with elevated minimum inhibitory concentration values for ciprofloxacin. The advisory outlines new guidance for clinical diagnosis, management, and reporting, and offers new recommendations for laboratories and public health officials. Recent data from the CDC, and from various state and local health agencies, indicate these strains frequently have a quinolone-resistance gene that could lead to clinically significant …
Read More